Sigma non-opioid receptor 1 is a potential therapeutic target for long QT syndromeLouJin Song(Pfizer (United States)), Masayuki Yazawa(Columbia University)Nature Cardiovascular ResearchFebruary 17, 202210.1038/s44161-021-00016-2Cited by 13SaveCiteExport RISWatch citationsRelated PapersDeveloping inhibitory peptides against SARS-CoV-2 envelope protein|PLoS Biology|2024|7after exercise training in myocardial-infarcted rats and MCT1 in cardiac muscle|Unknown|2015|0